Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GANX

Gain Therapeutics, Inc.

CIK 0001819411 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.00
↑ 0.02 (1.26%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$85.52M
P/E Ratio
-4.25
EPS
-0.61
Dividend Yield
Not covered
52W Position
17%
Beta
1.82

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
7.57
P/S
Not covered
EV/Revenue
Not covered
ROE
-178.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 17%
$1.53$4.34

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$20.16M
Total Assets
$22.82M
Free Cash Flow
–

Recent news